Intellectual Property India Publishes Patent Application for 4-Oxo-3,4-Dihydroquinazolinon Compounds For The Treatment Of Braf- Associated Diseases And Disorders

MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202418070012 A) filed by Array Biopharma Inc. on September 16, 2024, for 4-Oxo-3,4-Dihydroquinazolinon Compounds For The Treatment Of Braf- Associated Diseases And Disorders.

Inventors include Bettendorf, Tanna Marie; Doerner Barbour, Patrick Michael; Kahn, Dean Russell; Kellum, Alex Andrew; Laird, Ellen Ruth; Moreno, David Austin Number; and Ren, Li.

The application for the patent was published on July 17, 2026, under issue no. 29/2026.

Abstract: Provided herein is a compound of the Formula I: or a pharmaceutically acceptable salt thereof, wherein R1 , R2 , R3 , R4 , R5 , R6 , R7 and L are as defined herein, for the treatment of BRAF-associated diseases and disorders, including BRAF-associated tumors.

Disclaimer: Curated by HT Syndication.